GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Rockwell Medical Inc (NAS:RMTI) » Definitions » Cyclically Adjusted PB Ratio

Rockwell Medical (Rockwell Medical) Cyclically Adjusted PB Ratio : 0.28 (As of Jun. 06, 2024)


View and export this data going back to 1998. Start your Free Trial

What is Rockwell Medical Cyclically Adjusted PB Ratio?

As of today (2024-06-06), Rockwell Medical's current share price is $1.92. Rockwell Medical's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $6.89. Rockwell Medical's Cyclically Adjusted PB Ratio for today is 0.28.

The historical rank and industry rank for Rockwell Medical's Cyclically Adjusted PB Ratio or its related term are showing as below:

RMTI' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.14   Med: 4.56   Max: 19.58
Current: 0.26

During the past years, Rockwell Medical's highest Cyclically Adjusted PB Ratio was 19.58. The lowest was 0.14. And the median was 4.56.

RMTI's Cyclically Adjusted PB Ratio is ranked better than
91.53% of 732 companies
in the Drug Manufacturers industry
Industry Median: 1.885 vs RMTI: 0.26

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Rockwell Medical's adjusted book value per share data for the three months ended in Mar. 2024 was $0.698. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $6.89 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Rockwell Medical Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Rockwell Medical's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rockwell Medical Cyclically Adjusted PB Ratio Chart

Rockwell Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.82 1.44 0.69 0.16 0.28

Rockwell Medical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.27 0.81 0.31 0.28 0.24

Competitive Comparison of Rockwell Medical's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Rockwell Medical's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rockwell Medical's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Rockwell Medical's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Rockwell Medical's Cyclically Adjusted PB Ratio falls into.



Rockwell Medical Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Rockwell Medical's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=1.92/6.89
=0.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rockwell Medical's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Rockwell Medical's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.698/131.7762*131.7762
=0.698

Current CPI (Mar. 2024) = 131.7762.

Rockwell Medical Quarterly Data

Book Value per Share CPI Adj_Book
201406 -1.073 100.560 -1.406
201409 -1.464 100.428 -1.921
201412 15.029 99.070 19.991
201503 14.841 99.621 19.631
201506 14.453 100.684 18.916
201509 14.110 100.392 18.521
201512 13.311 99.792 17.577
201603 12.853 100.470 16.858
201606 12.303 101.688 15.943
201609 11.903 101.861 15.399
201612 11.305 101.863 14.625
201703 10.693 102.862 13.699
201706 9.322 103.349 11.886
201709 8.668 104.136 10.969
201712 6.994 104.011 8.861
201803 5.815 105.290 7.278
201806 3.589 106.317 4.448
201809 2.692 106.507 3.331
201812 5.261 105.998 6.540
201903 3.882 107.251 4.770
201906 5.134 108.070 6.260
201909 4.081 108.329 4.964
201912 3.419 108.420 4.156
202003 3.469 108.902 4.198
202006 2.542 108.767 3.080
202009 4.946 109.815 5.935
202012 4.017 109.897 4.817
202103 3.076 111.754 3.627
202106 2.134 114.631 2.453
202109 1.299 115.734 1.479
202112 0.297 117.630 0.333
202203 -0.563 121.301 -0.612
202206 2.141 125.017 2.257
202209 1.447 125.227 1.523
202212 1.160 125.222 1.221
202303 0.999 127.348 1.034
202306 0.567 128.729 0.580
202309 0.755 129.860 0.766
202312 0.731 129.419 0.744
202403 0.698 131.776 0.698

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Rockwell Medical  (NAS:RMTI) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Rockwell Medical Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Rockwell Medical's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Rockwell Medical (Rockwell Medical) Business Description

Traded in Other Exchanges
Address
30142 S. Wixom Road, Wixom, MI, USA, 48393
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. Rockwell Medical's mission is to provide dialysis clinics and patients with the highest quality products supported by the best customer service in the industry. It is focused on innovative, long-term growth strategies that enhance products, processes, and people, enabling the company to deliver exceptional value to the healthcare system and provide a positive impact on the lives of hemodialysis patients.
Executives
Jesse Neri officer: SVP, FINANCE 851 DUPORTAIL ROAD, SECOND FLOOR, CHESTERBROOK PA 19087
Joan Lau director C/O RENOVACOR, INC., 5 MEAD POINT DRIVE, GREENWICH CT 06830
Russell Skibsted officer: See Remarks 15 TRANQUILITY PLACE, LADERA RANCH CA 92694
Megan C. Timmins officer: SVP, General Counsel 600 LEE ROAD, SUITE 100, WAYNE PA 19087
Mark Strobeck director, officer: President and CEO 460 EAST SWEDESFORD ROAD, SUITE 1050, WAYNE PA 19087
Allen Nissenson director 601 HAWAII ST., EL SEGUNDO CA 90245
Robert S Radie director 101 LINDENWOOD DRIVE, SUITE 225, MALVERN PA 19355
Andrea Heslin Smiley director 600 LEE ROAD, SUITE 100, WAYNE PA 19087
David S. Richmond 10 percent owner, other: See Footnote 1 3568 WILDWOOD AVENUE, JACKSON MI 49202
Russell H Ellison director 270 RIVERSIDE DR., APT. 12D, NEW YORK NY 10025
Marc L Hoffman officer: Chief Medical Officer 30142 WIXOM ROAD, WIXOM MI 48393
John Peter Mclaughlin director C/O PDL BIOPHARMA, INC., 932 SOUTHWOOD BOULEVARD, INCLINE VILLAGE NV 89451
Richmond Brothers, Inc. 10 percent owner, other: See Footnote 1 7415 FOXWORTH COURT, JACKSON MI 49201
Stuart M Paul director, officer: Chief Executive Officer HOME DIAGNOSTICS, INC., 2400 NW 55TH COURT, FORT LAUDERDALE FL 33309
Angus W. Smith officer: Chief Financial Officer C/O PERNIX THERAPEUTICS HOLDINGS, INC., 10 NORTH PARK PLACE, SUITE 201, MORRISTOWN NJ 07960